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Trends Box 
x Amyloid fibres are proteinaceous filaments that form as a consequence 
of protein misfolding. Their formation is linked to over 50 human 
GLVHDVHV LQFOXGLQJ3DUNLQVRQ¶VDQG$O]KHLPHU¶VGLVHDVHs, and type 2 
diabetes mellitus. 
x Amyloid fibres are structurally polymorphic even when formed from the 
same sequence. The structure can alter their length distribution, 
thermodynamic stability, mechanical properties, and biological activity. 
x Amyloid fibres play a number of critical roles in disease, facilitating 
amyloid aggregate transmission, both between cells and, for prion-like 
species, between individuals. 
x Amyloid fibres also sequester core components of the proteostasis 
network, disrupt membranes, and catalyse or cause the formation of 
cytotoxic oligomers. 
x A comprehensive understanding of amyloid fibre biology will advance 
us towards our goal of therapeutic intervention. 
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Abstract 9 
The formation of amyloid fibres is a hallmark of amyloid disorders. Nevertheless, the 10 
lack of correlation between fibre load and disease as observed, for example, in 11 
$O]KHLPHU¶V GLVHDVH PHDQV fibres are considered secondary contributors to the 12 
onset of cellular dysfunction. Instead, soluble intermediates of amyloid assembly are 13 
often described as the agents of toxicity. Here, we discuss recent experimental 14 
discoveries which suggest that amyloid fibres should be considered as disease-15 
relevant species that can mediate a range of pathological processes. These include 16 
disruption of biological membranes, secondary nucleation, amyloid aggregate 17 
transmission, and the disruption of protein homeostasis (proteostasis). Thus, a 18 
greater understanding of amyloid fibre biology could enhance prospects of 19 
developing therapeutic interventions against this devastating class of protein 20 
misfolding disorders.  21 
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Historical perspective on the role of amyloid fibres in disease 22 
Amyloid diseases are a group of protein misfolding disorders defined by the 23 
formation and deposition of insoluble protein fibres with a cross-ȕIROG [1,2]. Although 24 
well known for their association with neurodegenerative disorders, such as 25 
$O]KHLPHU¶s DQG3DUNLQVRQ¶V diseases, amyloid fibre formation is involved in a range 26 
of human conditions, in which misfolded protein aggregates deposit in a localised or 27 
systemic fashion [3]. Despite the increasing incidence of amyloidoses in our ageing 28 
population, these disorders are remarkably difficult to prevent or ameliorate, since 29 
the myriad of misfolded species that can form during amyloid assembly has 30 
precluded the precise identification of the originators of toxicity. In addition, many 31 
amyloid diseases are exacerbated by ageing due to the reduced efficiency of the 32 
proteostasis machinery. This leads to increased protein misfolding and aggregation 33 
events that accelerate the decline in protein homeostasis and enhance susceptibility 34 
to amyloid toxicity [4,5]. 35 
Since their discovery, the pathological role of amyloid fibres has undergone a shifting 36 
view; from the original findings implicating fibres as the causative agent of disease 37 
[6], to current opinions, which describe fibres as inert end-stage products of 38 
aggregation. Several reasons are responsible for this shift in opinion: i) amyloid 39 
fibres, including those composed of amyloid beta (AE)1-40/42, D-synuclein, and islet 40 
amyloid polypeptide (IAPP), have been shown to display limited toxicity in 41 
comparison with oligomeric intermediates of their assembly [7], ii) the conserved 42 
cross-ȕIROG of the amyloid fibre core has emerged as an important functional motif in 43 
a range of organisms, including prokaryotes, eukaryotes, and even humans [8,9], 44 
and iii) amyloid fibres are highly stable thermodynamically, and are amongst the 45 
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strongest and stiffest of any known proteinaceous material [10]. Prion fibres, which 46 
are structurally homologous to amyloid fibres, are the exception to this current view, 47 
and are firmly established as key facilitators of the spreading and infectivity observed 48 
in prionopathies [11]. Notably, recent discoveries have also shown that disease-49 
associated amyloid fibres, including fibres formed from AE and D-synuclein, facilitate 50 
the spreading of amyloid formation in vivo [12±14]. 51 
Interest in amyloid fibres as disease-relevant agents has undergone a renaissance in 52 
recent years. Here, we examine evidence that places amyloid fibres as a key player 53 
in the persistence, progression and propagation of amyloid disease through an array 54 
of biological activities relevant to the long incubatory periods over which these 55 
disorders manifest. Thus, an understanding of amyloid fibre structure, dynamics, and 56 
biology may help to unravel the complexities of amyloid disease, and pave the way 57 
towards developing successful therapies against these disorders. 58 
Biological membranes and fibre-induced toxicity 59 
Amyloid formation proceeds, most often, when an unfolded or partially folded 60 
precursor partitions into an aggregation landscape in which intermolecular contacts 61 
drive the formation of multimeric protein complexes (Figure 1). Under µnormal¶ 62 
physiological conditions, the probability that a protein conformer aggregates can be 63 
enhanced by changes in the cellular environment. This can occur, for instance, 64 
during interactions with lipid bilayers, or changes in pH encountered upon entry into 65 
endosomes or lysosomes [15,16]. Mutation or truncation of the polypeptide 66 
sequence may also render a previously innocuous protein into an aggregation-prone 67 
species [17±19]. A myriad of structurally diverse oligomeric species can form on- or 68 
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off-pathway to the low energy minima occupied by amyloid fibres. These oligomers 69 
may initiate a cascade of diverse pathological responses [1].  70 
Although oligomers have been shown to act as the primary deleterious aggregate in 71 
cell toxicity assays [7,20,21], several investigations have shown that amyloid fibres 72 
also possess cytotoxic properties [22]. Moreover, amyloid fibres FRPSRVHG RI Į-73 
V\QXFOHLQ ȕ2m and lysozyme have been shown to exhibit toxicity at low nM 74 
concentrations, when taking into consideration particle molarity within a fibrous 75 
sample [23,24]. In some instances, lipid membranes may be crucial mediators of 76 
fibre-induced cellular damage (Key Figure: Figure 2). For example, amyloid fibres 77 
composed of wild-type ȕ2-microglobulin ȕ2m), the causative agent in dialysis-related 78 
amyloidosis (DRA), have been shown to interact with, and perturb, the bilayer 79 
structure of lipid vesicles (Key Figure: Figure 2A) [25,26]. The pH, the bilayer 80 
composition, ligand and co-factor binding, as well as the length of fibres can 81 
influence the extent to which these binding events cause membrane damage. For 82 
example, mild acidification of the solution conditions and a reduction in fibre length 83 
both enhance ȕ2m fibre-mediated bilayer disruption [24,27,28]. In addition, the 84 
presence of bis(monoacylglycero)phosphate (BMP) within the bilayer, a lipid 85 
enriched to ~15% of the total lipid composition within endosomal and lysosomal 86 
membranes, significantly increases the susceptibility of membranes to ȕ2m amyloid 87 
fibre-induced damage [27]. 88 
Other amyloid fibres can also compromise the integrity of synthetic and biological 89 
membranes: Fibres composed of polyQ-expanded Huntingtin exon 1 (HttEx1) or D-90 
synuclein, have been shown to bind and cause damage to synthetic liposomes in 91 
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vitro [23]. Moreover, D-synuclein fibres disrupt intracellular calcium homeostasis by 92 
permeabilising cell membranes, leading to the onset of programmed cell death [23]. 93 
Other studies have reported that the binding of AE fibres to cell membranes inhibits 94 
long-term potentiation in mice hippocampal brain slices [29]. In addition, the 95 
interaction between AE fibres and lipids can lead to the resolubilisation of amyloid 96 
fibreV LQWR µUHYHUVH¶ ROLJRPHUV (Key Figure: Figure 2B) [30]. These oligomers were 97 
reported to be indistinguishable from those generated during the formation of 98 
amyloid fibres, were toxic to primary neurons, and caused memory impairment in 99 
mice models of disease. Thus, amyloid fibre-membrane interactions can expand the 100 
structural repertoire of cytotoxic species that can exert aggregate-mediated toxicity. 101 
Direct binding to membranes is not the only mechanism by which fibres can induce 102 
membrane damage. Indeed, membrane disruption is caused by the elongation of 103 
IAPP fibres on the bilayer surface; hIAPP precursors embed within the membrane 104 
and structurally rearrange to form a seeding-competent nucleus [31]. The 105 
subsequent elongation of the E-sheet-rich seed leads to bilayer disruption [32]. A 106 
recent study also showed that membranes accelerate the rate of primary nucleation 107 
RIĮ-synuclein fibres by >1,000 fold [33]. Thus, in addition to serving as platforms for 108 
fibre-mediated toxicity, membranes can also increase fibre load.  109 
Secondary nucleation and fibre fragmentation 110 
In addition to damaging membranes, recent studies have uncovered other 111 
mechanisms by which amyloid fibres can contribute to disease. For example, fibre 112 
surfaces have been shown to catalyse secondary nucleation mechanisms that 113 
proliferate the formation of oligomers from AE1-42Į-synuclein or hIAPP monomers 114 
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(Key Figure: Figure 2C) [16,34±36]. Moreover, these secondary nucleation events 115 
can be the predominant pathway by which cytotoxic species are generated [35]. 116 
Additional secondary processes, such as fibre fragmentation [37], can also augment 117 
aggregation by increasing the number of templating fibre ends onto which soluble 118 
precursors are added (Key Figure: Figure 2D) [37,38]. Fibre fragmentation also 119 
enhances the uptake of amyloid fibres into endosomes and lysosomes, which can 120 
have devastating cellular consequences [24]. For example, the increased 121 
internalisation of fragmented ȕ2m fibres disrupts trafficking of membrane proteins to 122 
lysosomes and inhibits the capacity of lysosomes to degrade proteins (Key Figure: 123 
Figure 2E) [28]. Thus, secondary processes can drive amyloid disease by increasing 124 
the probability that fibres gain access to intracellular compartments (fragmentation), 125 
or by enhancing the local concentration of deleterious oligomers that form via 126 
surface-induced catalysis of nucleation (secondary nucleation). In support of the 127 
latter, a recent study showed that the molecular chaperone, BRICHOS, is able to 128 
inhibit secondary nucleation reactions catalysed by AE fibres and to reduce toxicity 129 
[34]. Thus, targeting secondary events may be a promising therapeutic strategy for 130 
ameliorating amyloid toxicity. 131 
Transmission and spreading: From cellular toxicity to pathogenic 132 
progression in an organism 133 
Perhaps the most significant activity attributed to amyloid fibres is the transmission of 134 
amyloid aggregation [11±14,39±41]. By contrast with their well-established toxicity, 135 
oligomers are relatively inefficient at propagating aggregation in vivo. This was 136 
recently demonstrated for D-synuclein aggregates in rat models of 137 
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synucleinopathies, whereby mature amyloid fibres, rather than oligomers, caused the 138 
most progressive motor impairment and cell death [41]. This phenomenon has been 139 
observed for other filamentous species within a multicellular organism. For example, 140 
in a C. elegans prion model cell-to-cell spreading of amyloid-like species occurs via 141 
endocytic uptake of fibrillar material from the extracellular space and is facilitated by 142 
autophagy-lysosomal mechanisms [42]. Rather than being degraded, prions 143 
accumulate in lysosomal, tubular structures that allow transmission between cells 144 
[42]. 145 
The immense thermodynamic stability of amyloid fibres may facilitate their enhanced 146 
infective capacity over their assembly intermediates by enabling fibres to persist in a 147 
variety of cellular environments [10]. Moreover, fibres are more resistant to 148 
proteolysis compared with their precursors, which further enhances their longevity in 149 
cellular compartments such as lysosomes [15,43]. Secondary processes can also 150 
enhance fibre transmissibility; fragmentation of D-synuclein fibres has been shown to 151 
lead to the more wide-spread deposition of fibres in vivo [44]. How aggregates 152 
traverse membrane barriers in order to seed aggregation within the cytosol of 153 
neighbouring cells is poorly understood. However, as described in this article, 154 
amyloid fibres bind to biological membranes, which may facilitate their penetration 155 
into the cytosol via membrane destabilisation and/or disruption. 156 
The endolysosomal pathway is emerging as a common route hijacked by insoluble 157 
aggregates in order to transmit aggregation and cause cellular degeneration 158 
[28,45,46]. For example, both Į-synuclein and polyglutamine expanded aggregates 159 
have been shown to be internalised by endocytosis and to seed aggregation within 160 
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the cytosol of previously uninfected cells [45,46]. 0RUHRYHU WKH SUHVHQFH RI Į-161 
synuclein aggregates within endosomes compounds cellular toxicity by inhibiting 162 
lysosomal degradation [47]. Strikingly, the inhibition of lysosomal degradation 163 
LQFUHDVHVWKHVHFUHWLRQRILQIHFWLYHĮ-synuclein species via exosomes [47]. Thus, the 164 
observed targeting of endolysosomal pathways by amyloid fibres constitutes a key 165 
mechanism that can explain the basis for intercellular spreading. Phagocytic 166 
processes in the intact brain driven by phagocytic glia constitutes another key 167 
access route that allows spreading of pathogenic protein aggregates as was recently 168 
shown in a Drosophila Huntington disease model [48] . Glial phagocytosis is usually 169 
a neuro-protective clearance mechanism that allows removal of extracellular protein 170 
aggregates [49,50]. However, uptake of mutant huntingtin aggregates with a 91 Q 171 
expansion (HttQ91) from affected neuronal axons by glial cells in close proximity can 172 
induce prion-like conversion of otherwise soluble HttQ25 proteins in the glial cell 173 
cytoplasm, and thus add to the systemic toxicity associated with amyloid fibre 174 
formation observed in cellular and whole-animal studies (Figure 3). 175 
Fibres as reservoirs of toxic oligomers  176 
Most of the biological activities of amyloid fibres discussed thus far can be attributed 177 
to a fibre as a static entity. However, despite their formidable thermodynamic 178 
stability, fibres are dynamic and readily exchange subunits within the soluble milieu 179 
(Key Figure: Figure 2F) [51±53]. Although µPROHFXODU VKHGGLQJ¶ is slow under 180 
conditions favouring fibre formation (~1x10-4.s-1, as determined for AE40 and SH3 181 
domain fibres [51,53]), such activity is likely to be biologically relevant, as suggested 182 
by the oligomeric halo surrounding AE fibrillar plaques in mice models of $O]KHLPHU¶V183 
disease [54]. The extent of molecular shedding can also be enhanced by changes in 184 
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the pH. As shown for E2m fibres, a reduction in pH by a single unit (from pH 7.4 ± 185 
6.4) causes the shedding of oligomers ~30 nm in diameter that are not observed by 186 
incubating fibres at pH 7.4, nor during fibre formation at pH 2 [55,56]. In order to 187 
FDXVHGHOHWHULRXVDFWLYLW\ȕ2m fibres must first be internalised from the extracellular 188 
milieu [24,27,28]. The reduction in pH encountered by internalised ȕ2m fibres during 189 
endosome maturation, coupled with the increase in BMP content within the bilayer, 190 
PD\ FUHDWH DQ HQYLURQPHQW XQLTXHO\ VXVFHSWLEOH WR ȕ2m fibre-mediated cellular 191 
dysfunction, by enhancing the release of membrane-active oligomers. For other 192 
fibres, the rate of molecular shedding can be influenced by protein sequence; the 193 
removal of the C-terminal two residues from AE1-42 enhances the rate of molecular 194 
shedding more than 60-fold [57].  195 
The importance of molecular shedding in contributing to amyloid toxicity is supported 196 
by the amelioration of toxicity upon restricting fibre dynamics For example, the 197 
molecular chaperones clusterin, DB-crystallin, hsp70, or hsc70 retard the rate of 198 
molecular shedding and reduce toxicity upon binding to AE ȕ2P RU Į-synuclein 199 
fibres, respectively [55,58,59]. Non-covalently bound small molecules may also be 200 
able to reduce molecular shedding of AE16-21 fibres [60]. Conversely, the human 201 
cytosolic hsp70 chaperone system involving hsc70, its co-chaperone DNAJB1 and 202 
nucleotide exchange factor Apg2 have been shown to  fragment and GLVDJJUHJDWHĮ-203 
synuclein amyloid fibres into monomers in an ATP-dependent mechanism leading to 204 
reduced toxicity [61]. Thus, preventing shedding of toxic species from amyloid fibres, 205 
or resolubilizing amyloid fibres to non-toxic species including monomers, may be 206 
useful therapeutic strategies for treating a range of amyloid disorders. 207 
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The amyloid strain phenomenon 208 
The concept of amyloid polymorphism and hence amyloid µstrainV¶ adds to the 209 
complexity of understanding the development and progression of disease in different 210 
individuals. Fibres formed from familial variants associated with early-onset 211 
phenotypes of amyloid disease could, for example, favour the formation of a 212 
structurally distinct fibre that exhibits a distinct dynamic signature from its wild-type 213 
counterpart. Such structural differences between amyloid fibre µVWUDLQV¶, which may 214 
be compounded by the genetic diversity in humans and the conditions under which 215 
amyloid formation proceeds, (Figure 1) may contribute to the unpredictable disease 216 
progression observed in individuals suffering from the same amyloid disorder 217 
[41,62]. For example, different D-V\QXFOHLQILEUHµVWUDLQV¶KDYHEHHQVKRZQWRH[KLELW218 
specific toxicities and prion-like transmissible properties, suggesting that amyloid 219 
fibre conformation can influence cell-to-cell aggregate transmission and disease 220 
progression [41,63]. Such conformation-dependent fibre toxicities have also been 221 
reported for AE1-40 [64]. A recent analysis using solid state NMR showed that single 222 
fibre polymorphs are faithfully propagated within WKH EUDLQ RI $O]KHLPHU¶V GLVHDVH223 
patients 7KXV GLVWLQFW ILEUH µVWUDLQV¶ PD\ IDFLOLWDWH differences in disease 224 
presentation, and, in some instances, may explain the lack of correlation between 225 
plaque load and disease progression [62]. 226 
Fibres as ELRORJLFDOµEODFNKROHV¶ 227 
While components of the proteostasis network (PN) have shown powerful inhibitory 228 
activity against amyloid toxicity, the unsolicited sequestration of proteins by amyloid 229 
fibres can also have catastrophic consequences. For example, fibres formed 230 
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intracellularly from de novo designed aggregation-prone polypeptides have been 231 
shown to sequester a wide range of cellular proteins [65]. These include molecular 232 
chaperones, as well as proteins involved in multiple cellular processes (Figure 3). 233 
Thus, fibres destabilise the PN by trapping vital components in dead-end interactions 234 
[66]. More specifically, insoluble intracellular deposits of E-sheet rich proteins 235 
sequester DnaJB1, an hsp40 co-chaperone, which is involved in transport of 236 
cytosolic misfolded proteins into the nucleus for proteasomal degradation by the 237 
ubiquitin-proteasome system (UPS) [65,67]. The enrichment of DnaJB1 within 238 
intracellular protein aggregates in turn inhibits the correct trafficking and degradation 239 
of natural misfolded substrates [67]. This leads to the proliferation of potentially toxic, 240 
non-amyloidogenic aggregates in the cell, thereby critically overloading the cellular 241 
capacity of the PN (Figure 3). A major contributing factor to this deleterious activity is 242 
the interaction of amyloid fibres with hydrophobic and flexible regions of pre-existent 243 
and newly synthesized proteins [65]. Therefore, in addition to sequestering key 244 
components of the PN, amyloid aggregates magnify their toxic and pathogenic 245 
potential by increasing the misfolding of already metastable components of the 246 
cellular proteome.  247 
Whereas the discussed findings illustrate how amyloid species disrupt the PN within 248 
cells and at a systemic level, recent discoveries made in invertebrate model 249 
organisms suggest that the PN itself has evolved to communicate local disturbances 250 
between cells and tissues [68]. Thus, in the context of an organism, the PN is 251 
organized in a cell nonautonomous manner and has transcellular stress response 252 
mechanisms at place that can counteract systemic disease progression. Pre-emptive 253 
activation of such transcellular stress responses may hold the potential for more 254 
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effective therapeutic strategies against disease progression and systemic toxic 255 
potential caused by amyloid fibres (Figure 3). 256 
Concluding remarks 257 
Here, we have summarized compelling evidence illustrating that amyloid fibres 258 
should not be considered as inert products of aggregation, but rather as important 259 
facilitators of the cellular degeneration and propagation of aggregation observed in 260 
amyloid disease. Thus, the idea that oligomers are the primary progenitor of amyloid 261 
disease needs to be revisited, and indeed all potential misfolded species, including 262 
monomers, oligomers and fibres themselves, should be recognised as potential 263 
contributors to amyloid disease. 264 
The study of amyloid fibre structure, dynamics, and biology has helped to illuminate 265 
the complex nature of amyloid diseases. Many key questions remain, including how 266 
do XQLTXHILEUHµVWUDLQV¶cause different biological effects by modulating fibre stability 267 
DQGG\QDPLFVDVZHOODV WKH ILEUH µLQWHUDFWRPH¶ (Outstanding Questions)? A better 268 
understanding of the degenerative effects that unique fibre morphologies can elicit 269 
will not only strengthen our understanding of the fundamental biology of amyloid 270 
disease, but further our goal of therapeutic intervention in this devastating group of 271 
protein-misfolding diseases. 272 
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Figure 1 The energy landscapes of protein folding and aggregation.  437 
Folding of proteins into their functional, native states takes place via the formation of 438 
metastable folding intermediates en route to the low energy native state (blue). 439 
Under certain conditions, such as changes in pH, or upon alteration of polypeptide 440 
sequence, protein misfolding can occur more frequently (red polypeptides). This 441 
creates aggregation-competent monomers that partition LQWR SDUDOOHO µPLVIROGLQJ¶442 
amyloid landscapes (red and yellow). The formation of amyloid is driven by 443 
intermolecular contacts and generates an array of multimeric protein complexes 444 
(oligomers) that precede the formation of highly-ordered, low-energy structures 445 
known as amyloid fibres. Depending upon the sequence or upon the conditions 446 
under which aggregation takes place (condition/sequence A or condition/sequence 447 
B), the ruggedness of the folding and amyloid landscapes can be altered. This can 448 
affect the probability of molecules misfolding, and entering the aggregation 449 
landscapes (not depicted here), and/or the stability and structure of fibres and 450 
oligomers formed (red and yellow landscapes). These alterations change the ability 451 
of an amyloid fibre, and of all species accessible within the particular landscape, to 452 
cause cellular dysfunction and degeneration. 453 
 454 
Key Figure. Figure 2 Amyloid fibres can elicit different biological activities. 455 
Fibres can (A) bind directly to lipid bilayers, causing deformations and membrane 456 
depolarisation (as indicated by red arrows). Similarly, (B) fibre:membrane 457 
interactions may promote the dissolution of fibres into cytotoxic oligomers that, 458 
among other activities, may also cause membrane disruption. (C) Fibre surfaces are 459 
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also catalytically active and can convert monomeric precursors into aggregation-460 
competent structures, while (D) fibre ends can consume aggregation competent 461 
species via templated elongation. (E) Fragmentation enhances fibre activity by 462 
increasing the ability of fibres to be internalised into the endosomal pathway. (F) 463 
Amyloid fibres can also undergo molecular shedding, whereby oligomeric species 464 
dissociate from fibre ends to generate a localised pool of potentially toxic oligomers. 465 
  466 
Figure 3 Proteostasis components affected by amyloid fibres and protective 467 
mechanisms. 468 
Intracellular components of the proteostasis network are impaired by the presence of 469 
amyloid fibres in the cytosol (yellow). Trafficking components are hijacked by 470 
amyloid species to facilitate intercellular spreading between different cells. 471 
Multicellular organisms may have developed defence strategies that allow cell 472 
nonautonomous activation of protective stress responses by transcellular stress 473 
signalling and components of the organismal proteostasis network. 474 
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Outstanding Questions 
x How does amyloid structure relate to disease pathology and 
progression? An array of structural polymorphisms is potentially 
accessible to aggregation-prone polypeptides. Understanding and 
identifying how distinct structural motifs GULYH µVWUDLQ¶-dependent 
toxicities may allow the progression of disease to become more 
predictable. 
x Do different fibre morphologies have distinct interactomes? The 
trapping of vital cellular components by fibres can lead to the collapse 
of the proteostasis network. Identifying the interactions made with 
individual fibre morphologies could elucidate plausible points of 
intervention for targeted therapeutic strategies. 
x What makes a fibril benign or toxic? 7KHµVWUDLQ¶SKHQRPHQRQKDVWKH
potential to explain why infectivity and fibre formation can be distinct 
processes
. 
Some fibre polymorphs may possess a greater capacity to 
catalyze secondary nucleation events, or undergo fragmentation, for 
example, and thus increase toxicity over other fibre morphologies. 
x How do amyloid fibres infect and spread between cells? Fibres are 
known to be able to access the cytosol when added extracellularly, but 
the mechanism by which this occurs remains poorly understood. 
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